Profile image
Story Views

Last Hour:
Last 24 Hours:

Cancer Monoclonal Antibodies Market 2017 Trends, Growth and Forecast to 2021

Monday, February 13, 2017 2:27
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.

Publisher’s analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.

For more information about this report: .                    

Covered in this report 
The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography: 

Publisher’s report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
-F. Hoffmann-La Roche
-Bristol-Myers Squibb
-Takeda Pharmaceuticals


Request Sample Copy at .                       


Other prominent vendors 
-ADC Therapeutics 
-Argos Therapeutics
-Astellas Pharma
-Biotech Pharmaceutical 
-Boehringer Ingelheim
-Celldex Therapeutics
-Chugai Pharmaceutical
-CTI BioPharma
-Daiichi Sankyo
-Eli Lilly
-Fortress Biotech
-Intas Pharmaceuticals
-Janssen Biotech
-Kyowa Hakko Kirin
-Neovii Biotech
-OncoMed Pharmaceuticals
-Seattle Genetics
-TG Therapeutics

Inquire for Report at .                       

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.